[Correlation of inhibition of thrombocyte light chain myosin phosphorylation and thrombocyte aggregation by the new calcium and calmodulin antagonist].
Aleksanian
A R
AR
Arutiunian
N S
NS
Galoian
A A
AA
Gerasimian
D A
DA
D001792:Blood Platelets / Q000187:drug effects* / Q000502:physiology; D002118:Calcium / Q000378:metabolism*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002147:Calmodulin / Q000037:antagonists & inhibitors*; D006801:Humans; D066298:In Vitro Techniques; D018994:Myosin Light Chains / Q000378:metabolism*; D010766:Phosphorylation / Q000187:drug effects; D010880:Piperidines / Q000494:pharmacology*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D013449:Sulfonamides / Q000494:pharmacology; D014700:Verapamil / Q000494:pharmacology
C107887:AR-1 (Ca channel blocker); D002121:Calcium Channel Blockers; D002147:Calmodulin; D018994:Myosin Light Chains; D010880:Piperidines; D010975:Platelet Aggregation Inhibitors; D013449:Sulfonamides; C017967:W 7; D014700:Verapamil; D002118:Calcium